Arrowstreet Capital Limited Partnership Invests $6.66 Million in GE HealthCare Technologies Inc. $GEHC

Key Points

• Arrowstreet Capital invested approximately $6.66 million in GE HealthCare Technologies during the first quarter by purchasing 93,620 shares. Institutional investors and hedge funds collectively own 82.06% of the company.
• GE HealthCare reported quarterly earnings of $1.13 per share, beating estimates of $1.04, while revenue rose 5.8% year over year to about $5.29 billion. The company also raised its full-year earnings outlook.
• Analyst sentiment is mixed, with 10 Buy, 10 Hold and one Sell rating; the consensus rating is Hold with a price target of $77.73, compared with shares opening at $68.02.

Arrowstreet Capital Limited Partnership purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 93,620 shares of the company's stock, valued at approximately $6,664,000.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company's stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co lifted its holdings in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock worth $278,725,000 after purchasing an additional 33,629,559 shares during the period. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company's stock valued at $2,559,945,000 after acquiring an additional 3,693,918 shares in the last quarter. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company's stock worth $2,080,248,000 after purchasing an additional 389,796 shares in the last quarter. Finally, State Street Corp raised its holdings in GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company's stock worth $1,644,475,000 after purchasing an additional 401,932 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on GEHC shares. Jefferies Financial Group lowered their price objective on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Royal Bank Of Canada assumed coverage on GE HealthCare Technologies in a research note on Tuesday, June 23rd. They set an "outperform" rating and a $80.00 target price for the company. The Goldman Sachs Group reissued a "neutral" rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Argus lowered their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a "buy" rating on the stock in a research note on Tuesday, May 19th. Finally, Piper Sandler reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Wednesday. Ten equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $77.73.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Better-than-expected earnings and raised guidance: GE HealthCare reported adjusted earnings of $1.13 per share, exceeding the $1.04 consensus estimate, while revenue of $5.30 billion also topped expectations. Revenue increased 5.8% year over year, and management raised its full-year EPS outlook. GE HealthCare Q2 2026 Earnings Call Summary
• Positive Sentiment: Record backlog and solid demand: Strong orders growth and a record backlog support expectations for future revenue growth and helped reinforce the bullish case for GEHC. Analysts highlighted the backlog as evidence of durable demand for the company’s medical technology and imaging products. GE HealthCare Q2 Earnings Call Highlights
• Positive Sentiment: Analyst support increased: Wells Fargo raised its price target from $75 to $85 and maintained an “overweight” rating. BTIG Research also forecast substantial appreciation, providing additional support for the shares. Wells Fargo Raises GE HealthCare Price Target
• Neutral Sentiment: Execution remains a key issue: Some analysis described demand as strong but execution as weaker, suggesting investors will watch margins, delivery performance and the company’s ability to convert its backlog into sustained earnings growth. GE HealthCare Strong Demand, Weak Execution
• Negative Sentiment: Shareholder investigations create legal uncertainty: Multiple law firms announced or continued investigations into possible securities-law violations and solicited investors who lost money. These announcements do not establish wrongdoing, but they may weigh on sentiment and raise potential litigation concerns. GEHC Securities Fraud Investigation

Insider Transactions at GE HealthCare Technologies

In related news, Director Watkin Phoebe L. Yang bought 1,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average price of $63.01 per share, with a total value of $63,010.00. Following the purchase, the director owned 13,702 shares in the company, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Rodney F. Hochman bought 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the acquisition, the director owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 12,618 shares of company stock valued at $805,175 in the last ninety days. Corporate insiders own 0.36% of the company's stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $68.02 on Monday. The stock has a market cap of $30.72 billion, a price-to-earnings ratio of 15.60, a PEG ratio of 1.97 and a beta of 0.69. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company's 50-day moving average price is $64.02 and its 200 day moving average price is $70.43. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.09. The firm had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm posted $1.06 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.91 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.21%.

GE HealthCare Technologies Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.